Archives

by in
Entry Author Date Location
Enanta Pockets $75M As AbbVie, Gilead Hep C Battle Begins 12/19/14 Boston
Arrowhead, Despite Ailing Stock, Reloads in RNAi Hepatitis B Fight 12/19/14 Wisconsin
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
Houston’s Bellicum Pharma Rides T-Cell Therapy Wave to $140M IPO 12/18/14 Texas
From American Well to Venture Capitalists, Health IT on the Rise 12/17/14 Boston
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software 12/16/14 New York
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight 12/16/14 National
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
Phytonix Turns Photosynthetic Bacteria Into Tiny Chemical Factories 12/15/14 Raleigh Durham
Big Events, Exits Raising Boston’s Innovation Profile at Year’s End 12/12/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Pioneer’s Lament: Lack of Checkpoint Immunotherapy For Blood Cancer 12/08/14 National
Bluebird 4 For 4 As Gene Therapy Helps More Blood Disease Patients 12/08/14 Boston
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
Boston Heart Diagnostics Bought by Eurofins for $140M 12/08/14 Boston
Independent No More: Cubist Sold to Merck for $9.5B 12/08/14 Boston
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug 12/07/14 San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
Xfund Closes $100M Fund as Venture Firms and Universities Get Cozier 12/04/14 Boston
Fast-Growing Maxwell Nets $26M More to Manage Your Healthcare 12/04/14 Boston
With Crossover Cash, Seres Health Aims For Big Microbiome Milestones 12/02/14 Boston
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
The Healthcare Summit 2014: The Photos 11/25/14 Boston
BioMarin Gambles $840M on Prosensa’s Duchenne Drug 11/24/14 San Francisco
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
Page 1 of 89 next page »